Evidence map›Paper›PMID 34055458›Full record

ArticleACS catalysis2019

Oxa- and Azabenzonorbornadienes as Electrophilic Partners under Photoredox/Nickel Dual Catalysis.

Youran Luo, Álvaro Gutiérrez-Bonet, Jennifer K Matsui, Madeline E Rotella, Ryan Dykstra, Osvaldo Gutierrez, Gary A Molander

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS catalysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. On the Nature of C(spJournal of the American Chemical Society · 2020
    Article
  7. Mechanisms, Challenges, and Opportunities of Dual Ni/Photoredox-Catalyzed C(spWiley interdisciplinary reviews. Computational molecular science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Youran LuoRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323 (USA).
Álvaro Gutiérrez-BonetRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323 (USA).
Jennifer K MatsuiRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323 (USA).
Madeline E Rotella0107 Chemistry Building, The Department of Chemistry and Biochemistry. University of Maryland. 8051 Regents Drive College Park, MD 20742 (USA).
Ryan Dykstra0107 Chemistry Building, The Department of Chemistry and Biochemistry. University of Maryland. 8051 Regents Drive College Park, MD 20742 (USA).
Osvaldo Gutierrez0107 Chemistry Building, The Department of Chemistry and Biochemistry. University of Maryland. 8051 Regents Drive College Park, MD 20742 (USA).
Gary A MolanderRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323 (USA).

Funding

Accessing New Chemical Space via Organic SynthesisR35GM131680 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOLANDER, GARY A · 2019 to 2022
$2.4M
A Novel Mechanistic Paradigm for Cross-CouplingR01GM113878 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOLANDER, GARY A · 2015 to 2018
$1.5M
NIGMS NIH HHS R01 GM113878NIGMS NIH HHS R35 GM131680
6 · The paper itself

Abstract

Herein, the introduction of oxa- and azabenzonorbornadienes into photoredox/nickel dual catalysis in a regioselective and diastereoselective transformation is disclosed. The inherent advantages of this dual catalytic system allow the use of alkyl motifs forming exclusively

Indexed as

4-AlkyldihydropyridinesCross-CouplingCurtin-HammettOxabenzonorbornadienePhotoredox/Nickel Dual CatalysisRegioselective

Identifiers

PMID34055458
PMCPMC8158860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.